At some point in their lifetime, one in 26 people will have epilepsy. If your child is struggling with a neurological condition, so many things can seem impossible: finding the right treatment, living ...

Epilepsy can be a scary diagnosis, and in children, the diagnosis not only effects the patients but can also effect the ...

More than 3.4 million people in the United States have epilepsy, so it is a relatively common diagnosis. In fact, it is the fourth-most common neurologic condition in the world. November is National ...

Unstoppable." That's how UC Davis Health pediatric epileptologist Trishna Kantamneni describes her 8-year-old patient, Savon ...

Childhood epilepsy affects roughly 4% of the pediatric population, and there are many different types of epilepsy and seizure frequency and intensity. 20% of patients have intractable epilepsy, which ...

Please provide your email address to receive an email when new articles are posted on . Pediatric patients with epilepsy treated with pharmaceutical CBD had better seizure control than those treated ...

Seizures, also known as fits or epilepsy, are characterized by abnormal movements, loss of consciousness, and peculiar behavior. Pediatric epilepsy can be caused by genetic factors, brain damage, ...

The pediatric epilepsy team at Johns Hopkins has used the ketogenic diet to treat more than 1,500 children since 1994 ...

Pediatric epilepsy significantly impacts sleep patterns for the child and parents, finds a research. Researchers from Massachusetts General Hospital for Children in Boston have determined that sharing ...

Abstracts from the American Epilepsy Society (AES) display potential benefits of cannabidiol (CBD) on pediatric patients with epilepsy in tertiary care centers and highlight areas where further ...

Our Lady of the Lake Children's Hospital opened a epilepsy monitoring unit on July 4, 2025, the first ever unit in the Baton Rouge area.

Pfizer Inc. PFE announced that the FDA has granted pediatric exclusivity to its epilepsy drug, Lyrica. With this grant, the exclusivity of the drug has been extended by six months to Jun 30, 2019. The ...